Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta‐Analysis of Randomized Controlled Trials
The Journal of Clinical Pharmacology · 2025
DOI: 10.1002/jcph.6154 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Giulia Almiron R Soares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Metropolitan University of Santos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Diarrhea, Bile Acids and Salts, Sequestering Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Bile acid sequestrants (BASs) have often been used for bile acid diarrhea (BAD) but carry a high risk of adverse events. New generations of BASs show promising results; however, their efficacy remains unclear. This systematic review and meta‐analysis was conducted using PubMed, Cochrane, and Embase to assess randomized controlled trials (RCTs) published up to November 2023 to retrieve studies that measured the parameters before and after the administration of BASs. The outcomes assessed were cessation or improvement in diarrhea, fecal consistency, abdominal cramping, frequency of diarrhea, and adverse events. Risk ratios (RRs) and mean differences with 95% confidence intervals (CIs) were pooled using a random‐effects model. Statistical analyses were conducted using RStudio version 4.1.2. The protocol was prospectively registered with PROSPERO (CRD42023445444). Seven RCTs with a total of 311 patients were included, of which 168 (54%) were randomized to BASs. Among BAS‐treated patients, 101 (60.1%) received colesevelam, 40 (23.8%) received chenodeoxycholate, 18 (10.7%) received cholestyramine, and 9 (5.3%) received colestid. BASs were associated with a significant improvement in the cessation of diarrhea (RR 3.27; 95% CI 2.08 to 5.15; P ≤ .05) and liquid stool to normal fecal consistency (RR 2.69; 95% CI 1.56 to 4.65; P ≤ .05), as well as an increase in abdominal cramps (RR 5.27; 95% CI 1.21 to 22.93; P ≤ .05). There were no differences in urgency, adverse events, or nausea between groups. These findings indicate that BASs are effective in the treatment of BAD, as indicated by the improvement or cessation of diarrhea episodes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Metropolitan University of Santos, São Paulo, Brazil.
- Cardiff University School of Medicine, Cardiff, UK.
- Federal University of the Southern Border, Passo Fundo, Brazil.
- Redentor University Center, Rio de Janeiro, Brazil.
- Department of Medicine, Federal University of Fluminense, Rio de Janeiro, Brazil.
- Metropolitan University of Santos, Santos, São Paulo, Brazil.
ORCID-Profile: Giulia Almiron R Soares, Estella Laia
Zitieren
APA
Soares, G. A. R., Godoi, A., Marcolin, P., Piredda, G., Laia, E., & Rodrigues, A. Z. (2025). Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta‐Analysis of Randomized Controlled Trials. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.6154
Vancouver
Soares GAR, Godoi A, Marcolin P, Piredda G, Laia E, Rodrigues AZ. Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta‐Analysis of Randomized Controlled Trials. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.6154
BibTeX
@article{Soares2025,
author = {Soares, Giulia Almiron R and Godoi, Amanda and Marcolin, Patricia and Piredda, Gabriel and Laia, Estella and Rodrigues, Airton Zogaib},
title = {Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta‐Analysis of Randomized Controlled Trials},
journal = {The Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/jcph.6154}
}
EUVIMED